FiercePharma19h
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Power Technology on MSN7d
Mitsubishi takes $342.4m impairment charge on domestic offshore wind
Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.
Mitsubishi Reviews Japanese Offshore Wind After Economic Changes
Mitsubishi Corp. is reviewing business plans for three Japanese offshore wind power projects following macroeconomic changes, ...
Mitsubishi reviews Japan offshore wind projects amid market shifts
Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...
The Mitsubishi MU-2: A Look At Japan’s Most Successful Post-War Aircraft
Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...
Bain Is Said to Near $3 Billion Deal for Mitsubishi Pharma Unit
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Reuters9d
Mitsubishi books $342 million charge on Japan offshore wind projects
TOKYO, Feb 6 (Reuters) - Japan's Mitsubishi Corp (8058.T), opens new tab took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in the nine-month period ...
Channel NewsAsia Singapore8d
Mitsubishi books US$439 million charge on Japan offshore wind projects
TOKYO: Japan's Mitsubishi Corp took a ¥66.8 billion (US$438.61 million) impairment charge on its domestic offshore wind ...